1. Home
  2. IDAI vs HSDT Comparison

IDAI vs HSDT Comparison

Compare IDAI & HSDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IDAI
  • HSDT
  • Stock Information
  • Founded
  • IDAI 2016
  • HSDT N/A
  • Country
  • IDAI United States
  • HSDT United States
  • Employees
  • IDAI N/A
  • HSDT N/A
  • Industry
  • IDAI Computer Software: Prepackaged Software
  • HSDT Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • IDAI Technology
  • HSDT Health Care
  • Exchange
  • IDAI Nasdaq
  • HSDT Nasdaq
  • Market Cap
  • IDAI 7.7M
  • HSDT 6.4M
  • IPO Year
  • IDAI N/A
  • HSDT N/A
  • Fundamental
  • Price
  • IDAI $2.98
  • HSDT $16.35
  • Analyst Decision
  • IDAI Strong Buy
  • HSDT Hold
  • Analyst Count
  • IDAI 1
  • HSDT 1
  • Target Price
  • IDAI $12.00
  • HSDT N/A
  • AVG Volume (30 Days)
  • IDAI 248.8K
  • HSDT 1.3M
  • Earning Date
  • IDAI 11-14-2025
  • HSDT 11-11-2025
  • Dividend Yield
  • IDAI N/A
  • HSDT N/A
  • EPS Growth
  • IDAI N/A
  • HSDT N/A
  • EPS
  • IDAI N/A
  • HSDT N/A
  • Revenue
  • IDAI $3,366,415.00
  • HSDT $295,000.00
  • Revenue This Year
  • IDAI $25.13
  • HSDT N/A
  • Revenue Next Year
  • IDAI $48.09
  • HSDT $75.13
  • P/E Ratio
  • IDAI N/A
  • HSDT N/A
  • Revenue Growth
  • IDAI N/A
  • HSDT N/A
  • 52 Week Low
  • IDAI $1.43
  • HSDT $5.37
  • 52 Week High
  • IDAI $18.75
  • HSDT $1,200.00
  • Technical
  • Relative Strength Index (RSI)
  • IDAI 48.84
  • HSDT 58.22
  • Support Level
  • IDAI $2.70
  • HSDT $16.02
  • Resistance Level
  • IDAI $4.42
  • HSDT $25.50
  • Average True Range (ATR)
  • IDAI 0.35
  • HSDT 2.61
  • MACD
  • IDAI -0.02
  • HSDT 1.30
  • Stochastic Oscillator
  • IDAI 16.28
  • HSDT 53.65

About IDAI T Stamp Inc.

T Stamp Inc develops and markets identity authentication software solutions for enterprise partners and peer-to-peer markets. The company is engaged in developing proprietary artificial intelligence-powered solutions; researching and leveraging biometric science, cryptography, and data mining to deliver insightful identity & trust predictions while identifying and defending against fraudulent identity attacks, protecting sensitive user information, and extending the reach of digital services through accessibility. The artificial intelligence-powered solutions segment generates revenue principally from software licenses, professional services, and recurring Software-as-a-Service ("SaaS") revenue.

About HSDT Helius Medical Technologies Inc. (DE)

Helius Medical Technologies Inc is a neurotech company focused on neurological wellness. The company's purpose is to develop, license, or acquire non-invasive technologies targeted at reducing symptoms of neurological disease or trauma. The company's product, known as the Portable Neuromodulation Stimulator (PoNS) is authorized for sale in Canada as a class II, a non-implantable medical device intended for use as a short-term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury and is to be used in conjunction with supervised therapeutic exercise.

Share on Social Networks: